Metallus has been downgraded from a buy to a hold rating despite improved profitability, as its valuation is considered full. The defense segment saw a 41% year-over-year revenue increase driven by new contracts, but fixed-price agreements keep cost control critical. Although Q3 EBITDA margin rose to 10.2% despite lower volumes, production costs continue to pressure results and cash flow remains negative. The discounted cash flow fair value of $20.16 per share is close to the current price, limiting upside potential unless stronger financial results or a lower entry price emerge.
Metallus is noted for a 41% year-over-year revenue increase in its defense segment, highlighting improved margins but limited upside due to valuation. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Nov 05, 2026 14:11 WIB: out of 83 priced US stocks, 59 rose and 20 fell today. Notable movers include Solstice Advanced Materials Inc. (SOLS) at USD 57.70 with a 1-day change of -6.54%, Amrize Ltd (AMRZ) at USD 44.69 up 6.48%, and AngloGold Ashanti Limited (AU) at USD 93.51 up 6.32% with a typical hold time of 51 days and Pluang order activity of 35% Sell / 65% Buy.
Purple has renewed its partnership with Lucid Motors to continue providing WiFi services across Lucid's operations in Riyadh. This renewal ensures that both staff and visitors have secure and easy internet access, supporting Lucid's growing presence ...
ACM Research reported a 37% year-over-year revenue increase to $367.7 million in Q3 2026, driven by strong demand in electrochemical plating (ECP) and advanced packaging technologies. The company is expanding manufacturing capacity and global sales e...
Investec Bank Plc, acting as joint broker to SThree Plc, disclosed public dealings involving the purchase and sale of 118,333 ordinary shares each on November 4, 2026. The transactions were conducted within a price range of 295 to 304 per share. Ther...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed transactions involving nearly one million ordinary shares on November 4, 2026. The bank purchased 999,970 shares at 1098 pence each and sold 962,128 shares at prices be...
Investec Bank Plc, acting as advisor and joint broker to Advanced Medical Solutions Group Plc, disclosed its share transactions on November 4, 2026. The bank purchased 35,908 ordinary shares at prices between 282.55 and 282.75 and sold 125,000 shares...
